Cancer Research

In the relentless fight against aggressive brain cancers, where progress is often measured in small, hard-won increments, a major clinical trial has delivered a monumental leap forward for a specific group of patients facing a daunting diagnosis. The recently concluded STELLAR Phase 3 clinical

Imagine a world where a single drug could shift the trajectory of blood cancer treatment, offering hope to thousands battling chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). At the recent American Society of Hematology (ASH) meeting in Orlando, Eli Lilly thrust its BTK

Imagine a world where living to 100 is common, yet the decline of mind and body feels just as relentless as it does today—where longer life doesn’t mean slower aging. This paradox lies at the heart of a provocative critique by Dr. Dan Ehninger and Dr. Maryam Keshavarz, published in Genomic

What if the key to beating the most common type of breast cancer lay hidden in the body's own defenses, waiting for science to unlock its potential? For the millions of women diagnosed with estrogen receptor-positive (ER-positive) breast cancer, which accounts for about 70% of all cases, a new

Today, we’re diving into the groundbreaking world of blood cancer research with Dr. Ivan Kairatov, a renowned biopharma expert whose deep knowledge of technology and innovation is driving transformative change in the fight against follicular lymphoma. As a key figure in the ERADICATE Follicular

Imagine a world where the most stubborn cancers, those that defy conventional treatments, can be halted not by destroying cells but by coaxing them into a state of permanent rest. This vision is inching closer to reality with a pioneering technology that harnesses the power of machine learning to